Cargando…
Rebuilding trust in proton pump inhibitor therapy
Introduction of proton pump inhibitor (PPI) therapy into clinical practice has revolutionized treatment approach to acid-related diseases. With its clinical success came a widespread use of PPI therapy. Subsequently, several studies found that PPIs were oftentimes overprescribed in primary care and...
Autores principales: | Turshudzhyan, Alla, Samuel, Sonia, Tawfik, Angela, Tadros, Micheal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260870/ https://www.ncbi.nlm.nih.gov/pubmed/35979162 http://dx.doi.org/10.3748/wjg.v28.i24.2667 |
Ejemplares similares
-
Lessons learned: Preventable misses and near-misses of endoscopic procedures
por: Turshudzhyan, Alla, et al.
Publicado: (2022) -
Cautious optimism in anticipation of hepatitis B curative therapies
por: Turshudzhyan, Alla, et al.
Publicado: (2022) -
Proton pump inhibitor: The dual role in gastric cancer
por: Joo, Moon Kyung, et al.
Publicado: (2019) -
Potassium-competitive acid blockers - are they the next generation of proton pump inhibitors?
por: Rawla, Prashanth, et al.
Publicado: (2018) -
Ethical dilemma of colorectal screening: What age should a screening colonoscopy start and stop?
por: Turshudzhyan, Alla, et al.
Publicado: (2021)